About Mesa Biotech
Mesa Biotech is a company based in San Diego (United States) founded in 2009 was acquired by Thermo Fisher Scientific in January 2021. Mesa Biotech has raised $26.8 million across 7 funding rounds from investors including Thermo Fisher Scientific, Public Health Emergency and NIH SBIR/STTR. The company has 131 employees as of December 31, 2020. Mesa Biotech offers products and services including Antibodies, Cell Culture Media, Chromatography Columns, and TaqMan Real-Time PCR Assays. Mesa Biotech operates in a competitive market with competitors including Inflammatix, Karius, Ansa Biotechnologies, Nuclera Nucleics and MeMed, among others.
- Headquarter San Diego, United States
- Employees 131 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$26.8 M (USD)
in 7 rounds
-
Latest Funding Round
$13 M (USD), Grant
Nov 06, 2020
-
Investors
Thermo Fisher Scientific
& 2 more
-
Employee Count
131
as on Dec 31, 2020
-
Acquired by
Thermo Fisher Scientific
(Jan 19, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mesa Biotech
Mesa Biotech offers a comprehensive portfolio of products and services, including Antibodies, Cell Culture Media, Chromatography Columns, and TaqMan Real-Time PCR Assays.
Tools for protein detection in research and diagnostics applications.
Nutrient solutions for growing cells in laboratory settings.
Components for separating mixtures in chemical analysis.
Kits for detecting genetic material in testing scenarios.
People of Mesa Biotech
Unlock access to complete
Unlock access to complete
Funding Insights of Mesa Biotech
Mesa Biotech has successfully raised a total of $26.8M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $13 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mesa Biotech
Mesa Biotech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Thermo Fisher Scientific, Public Health Emergency and NIH SBIR/STTR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Electron microscopy services and microanalysis instruments are provided.
|
Locked | Locked | Locked |
Investor details for Mesa Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mesa Biotech
Investment portfolio details for Mesa Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mesa Biotech
Detailed financials for Mesa Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mesa Biotech Comparisons
Peer comparison for Mesa Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mesa Biotech
Mesa Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, Ansa Biotechnologies, Nuclera Nucleics and MeMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
DNA synthesis technology using enzymes is provided.
|
|
| Locked | Locked | Locked |
Desktop bioprinter for genes and proteins production is developed.
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
Detailed competitors of Mesa Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mesa Biotech
Complete news archive for Mesa Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mesa Biotech
Mesa Biotech was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Mesa Biotech is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Mesa Biotech is a funded company, having raised a total of $26.8M across 7 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Mesa Biotech is 131.
Mesa Biotech was founded in 2009 in San Diego, United States, and operates in the molecular diagnostics sector. Point-of-care kits are provided through a reusable dock and disposable cassettes, enabling detection of pathogens and genetic targets in settings such as physicians offices or homes. The system supports multiplexed testing for human, agricultural, and food applications, with hardware designed for sensitivity and specificity comparable to lab-based methods.
Mesa Biotech's top competitors include Visby Medical, Nuclera Nucleics and Inflammatix.
Mesa Biotech offers Antibodies, Cell Culture Media, Chromatography Columns, and TaqMan Real-Time PCR Assays.
Mesa Biotech has 3 investors. Key investors include Thermo Fisher Scientific, Public Health Emergency, and NIH SBIR/STTR.